Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and Critical Illness

cidofovir anhydrous has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gattringer, KB; Jäger, W; Kraff, S; Thalhammer, F; Vossen, MG1
Anglada Martínez, H; Carcelero San Martín, E; Castro Rebollo, P; Soy Muner, D1

Other Studies

2 other study(ies) available for cidofovir anhydrous and Critical Illness

ArticleYear
Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Antiviral Agents; Cidofovir; Critical Illness; Cytosine; Hemofiltration; Humans; Male; Middle Aged; Organophosphonates; Probenecid

2014
[Cidofovir dosage in a critically ill patient undergoing continuous veno-venous hemodiafiltration].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Jan-01, Volume: 38, Issue:1

    Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Critical Illness; Cytosine; Female; Hemofiltration; Humans; Organophosphonates; Young Adult

2014